Showing results (301-310 of 335) with videos related to

Sort By:
Pageof 34
The Japanese Journal of Antibiotics|October 1, 1988
[Efficacy of ofloxacin in sexually transmitted male urethritis and cervicitis]Y Kumamoto, S Sakai, T Hirose, et al.
Genes, Brain, and Behavior|October 21, 2016
A new brain dopamine-deficient Drosophila and its pharmacological and genetic rescueK Cichewicz, E J Garren, C Adiele, et al.
Hinyokika Kiyo. Acta Urologica Japonica|October 1, 1987
[A double-blind trial on the effect of alpha-adrenergic blocker (bunazosin hydrochloride) in the symptomatic treatment of prostatism]Y Kumamoto, E Yokoyama, T Tsukamoto, et al.
Hinyokika Kiyo. Acta Urologica Japonica|October 1, 1988
[Endocrine therapy for prostatic carcinoma--the clinical trial to compare the efficacy of LH-RH analogue, ICI 118630 (Zoladex) with castration or estrogen]M Usami, T Kotake, M Matsuda, et al.
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|March 1, 1992
[Laparoscopic nephrectomy. Animal experiment and clinical application]E Higashihara, S Kameyama, Y Tanaka, et al.
The Journal of Clinical Endocrinology and Metabolism|April 1, 1990
Measurement of inhibin concentrations in men: study of changes after castration and comparison with androgen levels in testicular tissue, spermatic venous blood, and peripheral venous bloodH Ishida, H Tashiro, M Watanabe, et al.
Hinyokika Kiyo. Acta Urologica Japonica|December 1, 1988
[Clinical studies on the measurement of urinary tissue polypeptide antigen (TPA) levels using Prolifigen TPA kit "Daiichi"-II in urothelial cancers]H Ohmori, T Ohashi, Y Aso, et al.
Hinyokika Kiyo. Acta Urologica Japonica|October 1, 1986
[Treatment of prostatic carcinoma with daily subcutaneous injection of the LH-RH analogue, ICI 118630]M Usami, T Kotake, M Matsuda, et al.
Hinyokika Kiyo. Acta Urologica Japonica|March 1, 1991
[Clinical phase III study on TAP-144-SR, an LH-RH agonist depot formulation, in patients with prostatic cancer]Y Aso, S Kameyama, T Niijima, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|February 1, 1986
[Phase II collaborative study of (2''R)-4'-0-tetrahydropyranyladriamycin (THP) for urological malignancies--Urological Co-operative THP Study Group]T Niijima, T Koyanagi, S Sakashita, et al.
Pageof 34